Ophthalmology
Advertisement
A panel of experts discusses lotilaner ophthalmic solution 0.25%, the first FDA-approved treatment for Demodex blepharitis.
An ophthalmology panel explains the pros and cons of the current standard of care for treating Demodex blepharitis.
A panel of experts discusses how Demodex blepharitis presents and what treatment options are typically used.
A panel provides a breakdown on Demodex blepharitis, a prevalent ocular disease caused by an infestation of Demodex mites.
Fenofibrate significantly reduces the progression of diabetic retinopathy.
Researchers developed a contact lens that can potentially diagnose glaucoma by detecting changes in eye pressure.
Researchers have identified several novel gene variants related to the formation of glaucoma in Black people.
A study found unique risk factors for cardiovascular disease and mortality in patients with age-related macular degeneration.
Black and Hispanic patients face disparities when it comes to firearms-associated ocular injuries.
A team of researchers from the Indiana University School of Medicine have pinpointed a new therapeutic target that may ...
Research has suggested that sarcolemmal membrane-associated protein (SLMAP) is a driver in microvascular endothelial ...
Researchers, led by Takashi Nishida, MD, PhD, investigated the association between intraocular pressure variation and ...
Researchers investigated the impact of dual antiplatelet therapy on the progression of geographic atrophy (GA) in ...
In a recent randomized clinical trial in BMC Ophthalmology, researchers explored the potential of 1.0% phentolamine ...
In a study published in the Journal of Glaucoma, researchers evaluated the incidence of ocular hypertension in patients ...
For many children, wearing the correct glasses is crucially important to ensuring lifelong, healthy vision. While ...
Ehsan Rahimy, MD, moderates a discussion about hands-on experience with port delivery systems for patients with ...
In this segment of the round table series, moderator Ehsan Rahimy, MD, and panelists discuss the findings from the ...
The panel discusses the advancements they are most looking forward to in the neovascular AMD space, from new treatments ...
A recent survey conducted by The Harris Poll on behalf of Apellis Pharmaceuticals found that geographic atrophy (GA) – ...
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.